Noonan syndrome

Area of Science:

• Genetics
• Pediatrics
• Medical Genetics

Background:

• Noonan Syndrome (NS) is an autosomal dominant disorder affecting approximately 1 in 1000 to 2500 live births.
• Key features include short stature, distinctive facial morphology (hypertelorism, down-slanting palpebral fissures, ptosis, low-set ears), and congenital heart defects like pulmonary stenosis and hypertrophic cardiomyopathy.
• Additional manifestations encompass webbed neck, chest deformities, developmental delays, and lymphatic abnormalities.

Purpose of the Study:

• To provide a comprehensive overview of Noonan Syndrome, including its clinical presentation, genetic basis, diagnostic considerations, and management strategies.
• To highlight the genetic etiology, focusing on mutations in the PTPN11 and KRAS genes.
• To inform healthcare professionals about the importance of early diagnosis and multidisciplinary care for affected individuals.

Main Methods:

• Review of existing literature and clinical data on Noonan Syndrome.
• Genetic analysis, including mutation detection in genes such as PTPN11 and KRAS.
• Clinical assessment of characteristic physical and cardiovascular features.

Main Results:

• Noonan Syndrome is primarily caused by gain-of-function mutations in the PTPN11 gene (approx. 50% of cases) and less frequently in the KRAS gene.
• Characteristic facial features, short stature, and congenital heart defects are hallmarks of the syndrome.
• Prenatal diagnosis is possible in cases with polyhydramnion, hydrops fetalis, or increased nuchal translucency with a normal karyotype.

Conclusions:

• Noonan Syndrome requires a multidisciplinary approach, addressing feeding issues, cardiac function, growth, and developmental milestones.
• Early detection and intervention, including genetic testing and supportive therapies, are crucial for optimizing outcomes.
• While symptoms may lessen with age, ongoing monitoring and management are essential for individuals with Noonan Syndrome throughout their lives.